Review





Similar Products

anti phospho src  (MedChemExpress)
90
MedChemExpress anti phospho src
Anti Phospho Src, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/Phospho-Src+Family(Tyr416)+Antibody/pmc13624094-102-18-19
Average 90 stars, based on 1 article reviews
anti phospho src - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
p src  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc p src
P Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/Phospho-Src+(Tyr527)+Antibody/pm42815069-98-164-165
Average 96 stars, based on 1 article reviews
p src - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
p src tyr416  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc p src tyr416
P Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/Phospho-Src+Family+(Tyr416)+Rabbit+mAb/pm41855763-156-20-22
Average 96 stars, based on 1 article reviews
p src tyr416 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
pakt 5473  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc pakt 5473
Pakt 5473, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/Phospho-Src+(Ser17)+Antibody/us12594421-308-43-46
Average 94 stars, based on 1 article reviews
pakt 5473 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
phospho fak tyr397 3283s cell signaling src  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc phospho fak tyr397 3283s cell signaling src
Phospho Fak Tyr397 3283s Cell Signaling Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/Phospho-FAK+(Tyr397)+Antibody/us12594421-308-56-59
Average 96 stars, based on 1 article reviews
phospho fak tyr397 3283s cell signaling src - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
phospho src tyr416  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc phospho src tyr416
Phospho Src Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/Phospho-Src+Family+(Tyr416)+Antibody/us12594421-308-66-69
Average 96 stars, based on 1 article reviews
phospho src tyr416 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
phospho src family tyr416 d49g4 rabbit mab  (Cell Signaling Technology Inc)
86
Cell Signaling Technology Inc phospho src family tyr416 d49g4 rabbit mab
A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
Phospho Src Family Tyr416 D49g4 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/bio_rxiv__64898__2026__04__02__716058-74-6-39
Average 86 stars, based on 1 article reviews
phospho src family tyr416 d49g4 rabbit mab - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
phospho src y419 rabbit mab  (Huabio Inc)
86
Huabio Inc phospho src y419 rabbit mab
A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation <t>(Tyr416),</t> and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.
Phospho Src Y419 Rabbit Mab, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+src/anti+atm+mabhuabio+phospho+rabbit+recombinant+s1981/pmc13059770-339-0-40
Average 86 stars, based on 1 article reviews
phospho src y419 rabbit mab - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation (Tyr416), and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.

Journal: bioRxiv

Article Title: Heterogeneous Sensitivity to Src Inhibitors in Oral Squamous Cell Carcinoma and Its Implications for Combination Therapy with Cisplatin

doi: 10.64898/2026.04.02.716058

Figure Lengend Snippet: A Western blot analysis of the oral squamous carcinoma cell lines to monitor numerous signaling pathways. The phosphorylated and total protein levels were determined as indicated. B Cell viability (%) of the oral squamous carcinoma cell lines treated with each Src inhibitor for 72 h. Viability was measured using CellTiter-Glo, and values are indicated relative to the 1% dimethyl sulfoxide (DMSO) control. Data represent mean ± standard deviation from three independent experiments (n = 3). C IC50 curves of the oral squamous carcinoma cell lines treated with each Src inhibitor for 36 h. Viability was measured using CellTiter-Glo and normalized to that of the 1% DMSO control. Values represent the mean of n = 3. D, E Western blot analysis of the oral squamous carcinoma cell lines to investigate Src (D) and MAPK (E) activity induced by different Src inhibitors. Oral squamous carcinoma cell lines were treated with an Src inhibitor for 18 h, followed by western blot analysis. D indicates the Src phosphorylation (Tyr416), and E reveals MAPK pathway-related proteins. Supplementary Table S1 lists the concentrations of the Src inhibitors used.

Article Snippet: The following primary antibodies were used: Phospho-Src Family (Tyr416) (D49G4) Rabbit mAb (#6943), Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP Rabbit mAb (#4370), Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP Rabbit mAb (#4511), and Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb (#4668) (all from Cell Signaling Technology).

Techniques: Western Blot, Protein-Protein interactions, Control, Standard Deviation, Activity Assay, Phospho-proteomics